Showing results (71-80 of 325) with videos related to
Sort By:
Pageof 33
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 12, 2010
Adsorption of Bence-Jones protein to polymethylmethacrylate membrane in primary amyloidosisHiroyuki Hata, Kazuhiko Nishi, Wataru Oshihara, et al.Blood|January 25, 2007
Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemiaNorio Asou, Masatoshi Yanagida, Liqun Huang, et al.The Journal of Organic Chemistry|March 31, 2004
Indium-mediated atom-transfer and reductive radical cyclizations of iodoalkynes: synthesis and biological evaluation of HIV-protease inhibitorsReiko Yanada, Yasuhiro Koh, Nobuaki Nishimori, et al.British Journal of Haematology|February 13, 2003
A nitric oxide synthase inhibitor, N(G)-nitro-l-arginine-methyl-ester, exerts potent antiangiogenic effects on plasmacytoma in a newly established multiple myeloma severe combined immunodeficient mouse modelShima Uneda, Hiroyuki Hata, Fumihiko Matsuno, et al.Drug Development and Industrial Pharmacy|July 12, 2013
Preformulation studies of EFdA, a novel nucleoside reverse transcriptase inhibitor for HIV preventionWei Zhang, Michael A Parniak, Hiroaki Mitsuya, et al.Antiviral Research|March 18, 2014
Probing the molecular mechanism of action of the HIV-1 reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) using pre-steady-state kineticsYagmur Muftuoglu, Christal D Sohl, Andrea C Mislak, et al.Scientific Reports|January 28, 2018
HIV-1 with HBV-associated Q151M substitution in RT becomes highly susceptible to entecavir: structural insights into HBV-RT inhibition by entecavirYoshiaki Yasutake, Shin-Ichiro Hattori, Hironori Hayashi, et al.International Journal of Hematology|March 31, 2010
Successful treatment of Aspergillus liver abscesses in a patient with acute monoblastic leukemia using combination antifungal therapy including micafungin as a key drugRie Yamada, Kentaro Horikawa, Sonoko Ishihara, et al.Antimicrobial Agents and Chemotherapy|April 2, 2008
Potent synergistic anti-human immunodeficiency virus (HIV) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-HIV drugsHirotomo Nakata, Seth M Steinberg, Yasuhiro Koh, et al.Cancer Research|September 3, 2004
Identification of aberrantly methylated genes in association with adult T-cell leukemiaJun-Ichirou Yasunaga, Yuko Taniguchi, Kisato Nosaka, et al.Pageof 33